From: Eric Walker
>Maimon’s theory is essentially a rehash of older speculation - and is dead in >the water. Out of curiosity, whose are the earlier speculations? Early in the 1990s when Randell Mills presented evidence of thermal gain in Ni-H, there was speculation that this was related to the Mössbauer effect and to Auger Cascades. Mills was perhaps the leading expert on (medical uses) of Mössbauer and Auger spectroscopy. The isotope 57Fe is widely used in Mössbauer spectroscopy and it was thought Mills could have stumbled onto an isotope of Ni which did the same – but that was never shown to be true. This came to mind again when Rossi claimed to be enriching his Nickel with an isotope, but that too has never been verified. This list of Mills’ patents and patent applications shows that his medical and energy research was intermixed in time and place - and possibly overlapping with the Mossbauer, so that is intriguing. However there is no good evidence today that the hydrino or gain in Ni-H is related to the Mössbauer effect. US20050080260 Preparation of pro-drugs for selective drug delivery US20040247522 Hydrogen power, plasma, and reactor for lasing, and power conversion US20040118348 Microwave power cell, chemical reactor, and power converter US20040095705 Plasma-to-electric power conversion US20040027127 4 dimensional magnetic resonance imaging US20030228644 Pro drugs for selective drug delivery US20030129117 Synthesis and characterization of a highly stable amorphous silicon hydride as the product of a catalytic hydrogen plasma reaction US20020079440 Apparatus and method for providing an ant-gravitational force US20020051751 Pharmaceuticals and apparatus providing diagnosis and selective tissue necrosis US6555663 Pro-drugs for selective drug delivery US6477398 Resonant magnetic susceptibility imaging US6224848 Pharmaceuticals providing diagnosis and selective tissue necrosis using Mossbauer absorber atom US6024935 Lower-energy hydrogen methods and structures US5773592 Pro drugs for selective drug delivery US5428163 Pro-drugs for selective drug delivery US5221518 DNA sequencing apparatus US5073858 Magnetic susceptibility imaging (MSI) US5064754 Genomic sequencing method US4969469 Paramagnetic dynamo electromotive force detector and imaging system incorporating same US4815448 Mossbauer cancer therapy US4815447 Mossbauer cancer therapy
